Gemcitabine, Carboplatin, and Lenalidomide for Treatment of Advanced/Metastatic Urothelial Cancer and Other Solid Tumors

NCT01352962 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

NIH

Sponsor class

Conditions

Urethral Neoplasms
Neoplasms, Urethral
Cancer of the Urethra
Urethral Cancer

Interventions

DRUG: Gemcitabine
DRUG: Carboplatin
DRUG: Lenalidomide

Sponsor

National Cancer Institute (NCI)